CATALOG
CONTACT
ENG
ENG
CHN
KOR
ABOUT US
Company introduction
Leadership
History
Address
R&D
R&D
Patent registration
Paper presentation
Government Project
PRODUCTS
Human Tissue
Medical Device
NEWS&PR
Press
CHINA WORLD
CAREERS
CATALOG
CONTACT
엘앤씨바이오, 코로나·중국투자에도 1/4분기 매출·영업이익 고성장 지속
Writer 최고관리자
Date 21-05-14 17:46
Views 6,131

본문

연결재무제표 기준, 전년 대비 매출액 29%·영업이익액 19% 증가 


출처 : https://www.hankyung.com/finance/article/202105143319a

L&C Bio Co., Ltd. Business Registration No. (129-86-64008) Privacy Policy Seoul Office / R&D Center 82, Naruteo-ro, Seocho-gu, Seoul (Jamwon-dong) Seoul Office / Sales & Marketing Center Room 201, 105, HyoRyeong-ro (Beomchang Bldg., Bangbae-dong), Seocho-gu, Seoul Headquarters / Human Tissue Plant Units 605–607, 474, Dunchon-daero, Suntech City (Sangdaewon-dong), Jungwon-gu, Seongnam-si, Gyeonggi-do Pharmaceutical Plant Building A, 1F, 104, Gongdan 2-ro, (Sinsohyeon-dong), Anseong-si, Gyeonggi-do L&C ES Headquarters 2F #203–204, 90, Centum-dong-ro, L&C ES (Jaesong-dong, Centum Phil Bldg. 2), Haeundae-gu, Busan L&C ES R&D Center 4F, 76, Naruteo-ro (ImageUp Bldg.), Seocho-gu, Seoul L&C Medicare Headquarters Room 202, 105, HyoRyeong-ro (Beomchang Bldg., Bangbae-dong), Seocho-gu, Seoul L&C China Headquarters No. 97, Building 32-1, Jixiangnan Yuan, Luojia Town, Kunshan, Jiangsu, China
Cutomer Service
+82-2-541-8577
Copyright © 2015 L&C BIO lnc. All rights reserved